作者：
Bertoldo,F. [1]
;
Silvestris,F. [2]
;
Ibrahim,T. [3]
;
Cognetti,F. [4]
;
Generali,D. [5]
;
Ripamonti,C.I. [6]
;
Amadori,D. [7]
;
Colleoni,M.A. [8]
;
Conte,P. [9]
;
DelMastro,L. [10]
;
DePlacido,S. [11]
;
Ortega,C. [12]
;
Santini,D.
作者单位：
Oncology Unit, IRCC Candiolo, Torino, Italy
[1]
Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II
[2]
Department of Biomedical Sciences and Human Oncology, Section of Clinical Oncology, University of
[3]
Oncologia Medica 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
[4]
Department of Medical Oncology, University Campus Bio-Medico, Rome, Italy
[5]
UO Sviluppo Terapie Innovative, IRCCS AOU San Martino, IST, National Institute for Cancer Research
[6]
UO Multidisciplinare di Patologia Mammaria, US Terapia Molecolare e Farmacogenomica, AZ. Istituti
[7]
Department of Medicine, Universita' di Verona, Verona, Italy
[8]
Division Oncology, Regina Elena Institute, Rome, Italy
[9]
Division of Medical Senology, European Institute of Oncology, Milan, Italy
[10]
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei
[11]
Supportive Care in Cancer Unit, Department of Hematology and Pediatric Onco-Hematology, Fondazione
[12]
发布时间
2014-08-30
换一批
